HALOZYME THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Halozyme Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • Halozyme Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 127M shares, a 4.04% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 127M -5.32M -4.04% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 127M -4.48M -3.4% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 127M -8.38M -6.2% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 132M -3.13M -2.32% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 132M -5.83M -4.23% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 132M -6.23M -4.52% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 135M -2.34M -1.71% Dec 31, 2022 10-K 2024-02-20
Q3 2022 135M -5.76M -4.08% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 138M -4.5M -3.17% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 138M -5.49M -3.83% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 137M +2.47M +1.83% Dec 31, 2021 10-K 2023-02-21
Q3 2021 141M +5.6M +4.13% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 142M +5.51M +4.03% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 143M +8.02M +5.92% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 135M -1.68M -1.23% Dec 31, 2020 10-K 2022-02-22
Q3 2020 135M -11.1M -7.57% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 137M -9.19M -6.3% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 135M -10M -6.88% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 137M -8.01M -5.54% Dec 31, 2019 10-K 2021-02-23
Q3 2019 146M +1.94M +1.34% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 146M +1.64M +1.14% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 145M +1.48M +1.03% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 145M +1.94M +1.36% Dec 31, 2018 10-Q 2019-11-12
Q3 2018 145M +2.22M +1.56% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 144M +2.31M +1.63% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 144M +14.1M +10.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 143M +13.3M +10.3% Dec 31, 2017 10-K 2019-02-21
Q3 2017 142M +12.8M +9.9% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 142M +12.5M +9.66% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 130M +708K +0.55% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 130M +1.35M +1.05% Dec 31, 2016 10-K 2018-02-20
Q3 2016 129M +1.68M +1.31% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 129M +1.65M +1.29% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 129M +1.95M +1.53% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 128M +2.43M +1.93% Dec 31, 2015 10-K 2017-02-28
Q3 2015 128M +2.27M +1.8% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 128M +2.47M +1.97% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 127M +2.68M +2.15% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 126M +11.2M +9.77% Dec 31, 2014 10-K 2016-02-29
Q3 2014 126M +11.6M +10.1% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 125M +12M +10.6% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 124M +11.3M +10% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 115M +1.82M +1.62% Dec 31, 2013 10-K 2015-03-02
Q3 2013 114M +1.29M +1.15% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 113M +597K +0.53% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 113M +732K +0.65% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 113M +8.72M +8.39% Dec 31, 2012 10-K 2014-02-28
Q3 2012 113M +9.04M +8.73% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 113M +9.08M +8.76% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 112M Mar 31, 2012 10-Q 2012-05-07
Q4 2011 104M +3.41M +3.39% Dec 31, 2011 10-K 2013-03-01
Q3 2011 104M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 104M Jun 30, 2011 10-Q 2011-08-05
Q4 2010 101M Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.